文献速递复苏、休克与脓毒症创伤与烧伤

心肌球衍生细胞来源细胞外囊泡作为潜在抗休克治疗

Extracellular vesicles derived from cardiosphere-derived cells as a potential antishock therapeutic.
PubMed 文献 · J Trauma Acute Care Surg · 2021-01-01
一句话结论大鼠多伤合并失血性休克模型中,早期给予CDC-EVs可显著降低乳酸和肌酐升高,且不加重急性创伤性凝血病。

本研究在大鼠多伤合并失血性休克诱导的急性创伤性凝血病模型中,评估心肌球衍生细胞来源细胞外囊泡(CDC-EVs)的治疗潜力。体外实验显示CDC-EVs不具促凝功能、不干扰血小板功能。体内实验表明早期给予CDC-EVs可显著降低乳酸和肌酐升高,且不显著加重凝血病。结果提示CDC-EVs若早期给药可能成为抗休克治疗,值得在创伤救治中进一步研究。

要点

  • 在大鼠多伤合并失血性休克模型中,早期给予CDC-EVs显著降低乳酸和肌酐升高,提示可能改善休克相关代谢紊乱。
  • CDC-EVs在体外不具促凝功能且不干扰血小板功能,在体内不显著加重急性创伤性凝血病。
  • 研究为动物实验,CDC-EVs的临床疗效和安全性尚需进一步验证。
  • 结果支持CDC-EVs在创伤救治中超越其已知心脏保护作用进行扩展研究。

适用人群与场景

  • 大鼠多伤合并失血性休克诱导的急性创伤性凝血病模型;原文未提及具体纳入/排除标准或临床适用人群。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 在大鼠模型中早期给予CDC-EVs;原文未提及具体剂量、给药途径、频次或疗程。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:动物实验(大鼠模型);样本量未提及。
  • 体外实验:流式细胞术检测EV表面促凝分子(组织因子和磷脂酰丝氨酸);校准血栓图检测EV致血栓性;流动粘附模型评估凝血参数。
  • 体外结果:CDC-EVs不具功能性促凝作用,不干扰血小板功能。
  • 体内结果:在大鼠多伤合并失血性休克模型中,早期给予EVs显著降低乳酸和肌酐升高,且不显著加重急性创伤性凝血病。

证据类型、等级与局限

  • 证据类型:动物实验(大鼠模型);证据等级未提及;局限包括动物模型结果不能直接外推至临床,样本量未提及。

对床旁实践的改变

  • 原文未提及对急诊/ICU具体实践的改变;结果仅提示CDC-EVs作为潜在抗休克治疗需进一步研究。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Extracellular vesicles (EVs) isolated from cardiosphere-derived cells (CDC-EVs) are coming to light as a unique cell-free therapeutic. Because of their novelty, however, there still exist prominent gaps in knowledge regarding their therapeutic potential. Herein the therapeutic potential of CDC-EVs in a rat model of acute traumatic coagulopathy induced by multiple injuries and hemorrhagic shock is outlined.

METHODS: Extracellular vesicle surface expression of procoagulant molecules (tissue factor and phosphatidylserine) was evaluated by flow cytometry. Extracellular vesicle thrombogenicity was tested using calibrated thrombogram, and clotting parameters were assessed using a flow-based adhesion model simulating blood flow over a collagen-expressing surface. The therapeutic efficacy of EVs was then determined in a rat model of acute traumatic coagulopathy induced by multiple injuries and hemorrhagic shock.

RESULTS: Extracellular vesicles isolated from cardiosphere-derived cells are not functionally procoagulant and do not interfere with platelet function. In a rat model of multiple injuries and hemorrhagic shock, early administration of EVs significantly reduced the elevation of lactate and creatinine and did not significantly enhance coagulopathy in rats with acute traumatic coagulopathy.

CONCLUSION: The results of this study are of great relevance to the development of EV products for use in combat casualty care, as our studies show that CDC-EVs have the potential to be an antishock therapeutic if administered early. These results demonstrate that research using CDC-EVs in trauma care needs to be considered and expanded beyond their reported cardioprotective benefits.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Chance TC, Wu X, Keesee JD, et al. Extracellular vesicles derived from cardiosphere-derived cells as a potential antishock therapeutic. J Trauma Acute Care Surg. 2021. PMID: 34108422. doi:10.1097/TA.0000000000003218

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。